| 000 | 01520 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518003831.0 | ||
| 264 | 0 | _c20190314 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1745-6215 | ||
| 024 | 7 |
_a10.1186/s13063-018-2957-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZou, Constance X | |
| 245 | 0 | 0 |
_aRegistration, results reporting, and publication bias of clinical trials supporting FDA approval of neuropsychiatric drugs before and after FDAAA: a retrospective cohort study. _h[electronic resource] |
| 260 |
_bTrials _cOct 2018 |
||
| 300 |
_a581 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aCentral Nervous System Agents _xadverse effects |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xmethods |
| 650 | 0 | 4 | _aData Accuracy |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMental Disorders _xdiagnosis |
| 650 | 0 | 4 | _aPublication Bias |
| 650 | 0 | 4 | _aRegistries |
| 650 | 0 | 4 | _aResearch Design |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aBecker, Jessica E | |
| 700 | 1 | _aPhillips, Adam T | |
| 700 | 1 | _aGarritano, James M | |
| 700 | 1 | _aKrumholz, Harlan M | |
| 700 | 1 | _aMiller, Jennifer E | |
| 700 | 1 | _aRoss, Joseph S | |
| 773 | 0 |
_tTrials _gvol. 19 _gno. 1 _gp. 581 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-018-2957-0 _zAvailable from publisher's website |
| 999 |
_c28970025 _d28970025 |
||